688526 Stock Overview
Focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China.
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 5/6 |
| Past Performance | 2/6 |
| Financial Health | 5/6 |
| Dividends | 4/6 |
Wuhan Keqian Biology Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥13.50 |
| 52 Week High | CN¥20.79 |
| 52 Week Low | CN¥11.00 |
| Beta | 0.57 |
| 11 Month Change | 10.84% |
| 3 Month Change | -8.10% |
| 1 Year Change | -34.72% |
| 33 Year Change | -51.94% |
| 5 Year Change | n/a |
| Change since IPO | -57.25% |
Recent News & Updates
These 4 Measures Indicate That Wuhan Keqian BiologyLtd (SHSE:688526) Is Using Debt Reasonably Well
Sep 26
Investors Continue Waiting On Sidelines For Wuhan Keqian Biology Co.,Ltd (SHSE:688526)
Aug 20Recent updates
These 4 Measures Indicate That Wuhan Keqian BiologyLtd (SHSE:688526) Is Using Debt Reasonably Well
Sep 26Investors Continue Waiting On Sidelines For Wuhan Keqian Biology Co.,Ltd (SHSE:688526)
Aug 20We Think Wuhan Keqian BiologyLtd (SHSE:688526) Can Stay On Top Of Its Debt
Jun 26Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Stock Rockets 25% But Many Are Still Ignoring The Company
Apr 08Analysts Are More Bearish On Wuhan Keqian Biology Co.,Ltd (SHSE:688526) Than They Used To Be
Apr 05Earnings Miss: Wuhan Keqian Biology Co.,Ltd Missed EPS By 25% And Analysts Are Revising Their Forecasts
Apr 03Wuhan Keqian BiologyLtd (SHSE:688526) Has A Rock Solid Balance Sheet
Mar 20Shareholder Returns
| 688526 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | 19.2% | 6.5% | 9.6% |
| 1Y | -34.7% | -14.9% | -12.3% |
Return vs Industry: 688526 underperformed the CN Pharmaceuticals industry which returned -14.9% over the past year.
Return vs Market: 688526 underperformed the CN Market which returned -12.3% over the past year.
Price Volatility
| 688526 volatility | |
|---|---|
| 688526 Average Weekly Movement | 5.0% |
| Pharmaceuticals Industry Average Movement | 5.1% |
| Market Average Movement | 5.4% |
| 10% most volatile stocks in CN Market | 8.4% |
| 10% least volatile stocks in CN Market | 3.7% |
Stable Share Price: 688526 has not had significant price volatility in the past 3 months.
Volatility Over Time: 688526's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2001 | 903 | Mulin Chen | www.kqbio.com |
Wuhan Keqian Biology Co.,Ltd focuses on the research and development, production, sales, and animal epidemic prevention technical services of veterinary biological products in China. It offers vaccines for swine, poultry, and pets, as well as diagnostic reagents. The company was incorporated in 2001 and is based in Wuhan, China.
Wuhan Keqian Biology Co.,Ltd Fundamentals Summary
| 688526 fundamental statistics | |
|---|---|
| Market cap | CN¥5.87b |
| Earnings (TTM) | CN¥309.38m |
| Revenue (TTM) | CN¥932.75m |
20.3x
P/E Ratio6.7x
P/S RatioIs 688526 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 688526 income statement (TTM) | |
|---|---|
| Revenue | CN¥932.75m |
| Cost of Revenue | CN¥333.12m |
| Gross Profit | CN¥599.62m |
| Other Expenses | CN¥290.24m |
| Earnings | CN¥309.38m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.67 |
| Gross Margin | 64.29% |
| Net Profit Margin | 33.17% |
| Debt/Equity Ratio | 6.2% |
How did 688526 perform over the long term?
See historical performance and comparison